Manhattan Behavioral Medicine, PLLC — New York, New York

Manhattan Behavioral Medicine, PLLC is a clinical research site located in New York, New York, United States 10036.

Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

Manhattan Behavioral Medicine, PLLC has participated in 12 clinical trials.

Therapeutic areas: Obsessive Compulsive Disorder, Obsessive-Compulsive Disorder, Schizophrenia.

Sponsors: Biohaven Pharmaceuticals, Inc., Karuna Therapeutics, Inc., a Bristol Myers Squibb company, Xenon Pharmaceuticals Inc..

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Manhattan Behavioral Medicine, PLLC?

Manhattan Behavioral Medicine, PLLC has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Manhattan Behavioral Medicine, PLLC conducted?

Manhattan Behavioral Medicine, PLLC has 12 clinical trials on record. Their work covers Obsessive Compulsive Disorder, Obsessive-Compulsive Disorder, Schizophrenia.

Is Manhattan Behavioral Medicine, PLLC accredited by Crixeo Health?

Yes — Manhattan Behavioral Medicine, PLLC holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Manhattan Behavioral Medicine, PLLC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.